Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.131.90 CHF
Change Today -1.60 / -1.20%
Volume 333.8K
As of 11:43 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jean-Paul Clozel M.D.

Founder, Chief Executive Officer and Director,Actelion Ltd.
AgeTotal Calculated CompensationThis person is connected to 18 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Jean-Paul Clozel, M.D, founded Actelion Ltd. (alternate name Actelion AG ) in 1997 and has been its Chief Executive Officer since April 2000. Mr. Clozel was a Practicing Cardiologist for 11 years, from 1974 to 1985. He served as the Head of Drug Discovery Group in the Cardiovascular Department of F. Hoffmann-La Roche for 12 years, from 1985 to 1997. He serves as a Director of Actelion Ltd. and Actelion Pharmaceuticals Ltd. He served as a Professor to the Chairman ...

Read Full Background

Corporate Headquarters*

Gewerberstrasse 16
Allschwil, Basel-Landschaft 4123


Phone: 41 61 565 65 65
Fax: 41 61 565 65 00

Board Members Memberships*

Founder, Chief Executive Officer and Director


Universite De Montreal, L'

Other Affiliations*

Annual Compensation*

Total Annual CompensationSFr.2,652,671

Stock Options*

Restricted Stock AwardsSFr.3,277,135
All Other CompensationSFr.936,623

Total Compensation*

Total Annual Cash CompensationSFr.3,589,294
Total Short Term CompensationSFr.2,652,671
Other Long Term CompensationSFr.4,213,758
Total Calculated CompensationSFr.6,866,429
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.131.90 CHF -1.60


Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
Kare Schultz Chief Executive Officer and President
H. Lundbeck A/S
Jean-Christophe Tellier Chief Executive Officer and Executive Director
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
Said Samih Taleb Darwazah Chairman and Chief Executive Officer
Hikma Pharmaceuticals PLC
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at